| Jana Koehn, | |
|
4 Academy Pl Apt 307, Nashville, TN 37210-2278 | |
| (316) 243-7921 | |
| Not Available |
| Full Name | Jana Koehn |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 4 Academy Pl Apt 307, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003301284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 216665 (Tennessee) | Primary |
| 163W00000X | Registered Nurse | 216665 (Tennessee) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Ukiah Valley | Ukiah, CA | Hospital |
| Adventist Health Howard Memorial | Willits, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Amsurg Oakland Anesthesia Lp | 8224292123 | 16 |
| Anesthesia Management Services Of California Inc | 0840626040 | 8 |
| In Somno Securitas A Professional Nursing Corporation | 6709271356 | 10 |
| Willits Hospital Inc | 7416940697 | 54 |
News Archive
Dozens of American youth under the age of 20 die on the job each year while thousands more are injured, often due to poorly regulated work environments, according to a new report released by the Colorado School of Public Health.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
› Verified 7 days ago
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
Dozens of American youth under the age of 20 die on the job each year while thousands more are injured, often due to poorly regulated work environments, according to a new report released by the Colorado School of Public Health.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
› Verified 7 days ago
| Entity Name | Willits Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356339543 PECOS PAC ID: 7416940697 Enrollment ID: O20040405000843 |
News Archive
Dozens of American youth under the age of 20 die on the job each year while thousands more are injured, often due to poorly regulated work environments, according to a new report released by the Colorado School of Public Health.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
› Verified 7 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
Dozens of American youth under the age of 20 die on the job each year while thousands more are injured, often due to poorly regulated work environments, according to a new report released by the Colorado School of Public Health.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
› Verified 7 days ago
| Entity Name | Amsurg Oakland Anesthesia Lp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679847727 PECOS PAC ID: 8224292123 Enrollment ID: O20120605000461 |
News Archive
Dozens of American youth under the age of 20 die on the job each year while thousands more are injured, often due to poorly regulated work environments, according to a new report released by the Colorado School of Public Health.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
› Verified 7 days ago
| Entity Name | Anesthesia Management Services Of California Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003458704 PECOS PAC ID: 0840626040 Enrollment ID: O20200206002375 |
News Archive
Dozens of American youth under the age of 20 die on the job each year while thousands more are injured, often due to poorly regulated work environments, according to a new report released by the Colorado School of Public Health.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
› Verified 7 days ago
| Entity Name | In Somno Securitas A Professional Nursing Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114686631 PECOS PAC ID: 6709271356 Enrollment ID: O20220316003933 |
News Archive
Dozens of American youth under the age of 20 die on the job each year while thousands more are injured, often due to poorly regulated work environments, according to a new report released by the Colorado School of Public Health.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jana Koehn, 4 Academy Pl Apt 307, Nashville, TN 37210-2278 Ph: (316) 243-7921 | Jana Koehn, 4 Academy Pl Apt 307, Nashville, TN 37210-2278 Ph: (316) 243-7921 |
News Archive
Dozens of American youth under the age of 20 die on the job each year while thousands more are injured, often due to poorly regulated work environments, according to a new report released by the Colorado School of Public Health.
A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.
› Verified 7 days ago
Amanda B Dickert I, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1215 21st Ave S, Nashville, TN 37232 Phone: 615-343-6336 Fax: 615-343-1966 | |
Charles Ryan Swafford, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike, Suite 435, Nashville, TN 37205 Phone: 615-385-3704 Fax: 615-292-1321 | |
Jon Schwindt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 110 29th Ave N, Ste 202, Nashville, TN 37203 Phone: 615-327-4304 | |
Mrs. Misty Coggins Handy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 110 29th Ave N, Ste 202, Nashville, TN 37203 Phone: 615-327-4304 | |
Joshua Lemay, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 110 29th Ave N, Suite 202, Nashville, TN 37203 Phone: 615-327-4304 Fax: 615-327-7940 | |
Jonathan Keith Allgood, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike, Suite 435, Nashville, TN 37205 Phone: 615-385-3704 Fax: 615-292-1321 |